Pediatrix Medical Group, Inc.
General ticker "MD" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $1.5B (TTM average)
Pediatrix Medical Group, Inc. follows the US Stock Market performance with the rate: 50.6%.
Estimated limits based on current volatility of 1.6%: low 21.22$, high 21.92$
Factors to consider:
- Total employees count: 2150 as of 2024
- Top business risk factors: Government reimbursement changes, Economic downturns and volatility, Market volatility, Management turnover, Strategic risks and growth management
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [16.58$, 26.25$]
- 2026-12-31 to 2027-12-31 estimated range: [16.94$, 26.97$]
Financial Metrics affecting the MD estimates:
- Positive: with PPE of 10.8 at the end of fiscal year the price was neutral
- Positive: Operating cash flow per share per price, % of 14.56 > 12.90
- Positive: 7.54 < Operating profit margin, % of 10.91
- Positive: Interest expense per share per price, % of 1.93 <= 3.31
- Negative: Industry operating cash flow per share per price (median), % of 5.14 <= 5.46
- Positive: 19.24 < Shareholder equity ratio, % of 38.54 <= 42.59
- Positive: -9.55 < Industry operating profit margin (median), % of 0.04
Short-term MD quotes
Long-term MD plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,994.64MM | $2,003.22MM | $1,913.85MM |
| Operating Expenses | $1,987.32MM | $2,071.93MM | $1,705.04MM |
| Operating Income | $7.32MM | $-68.71MM | $208.81MM |
| Non-Operating Income | $-55.68MM | $-32.63MM | $7.62MM |
| Interest Expense | $42.08MM | $40.74MM | $35.97MM |
| Income(Loss) | $-48.36MM | $-101.34MM | $216.43MM |
| Taxes | $12.05MM | $-2.27MM | $51.04MM |
| Net Income(Loss)* | $-60.41MM | $-99.07MM | $165.39MM |
| Stockholders Equity | $849.06MM | $764.94MM | $865.85MM |
| Assets | $2,219.81MM | $2,152.70MM | $2,246.70MM |
| Operating Cash Flow | $137.32MM | $206.57MM | $271.09MM |
| Capital expenditure | $33.33MM | $22.02MM | $18.46MM |
| Investing Cash Flow | $-48.18MM | $-35.41MM | $-18.30MM |
| Financing Cash Flow | $-25.71MM | $-14.48MM | $-107.49MM |
| Earnings Per Share** | $-0.72 | $-1.19 | $1.94 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.